Delivery Order SPE2DB22D9316-SPE2DB24FYP60
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a $4,254.96 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The order is for the supply of 4564220840 - PERJETA 420 MG/14 ML VIAL 14ML, a pharmaceutical product. This order is part of a larger indefinite delivery vehicle (IDV) contract, contract 4600082013 under the SPE2DB program, with a ceiling value of up to $4,999,999 through the end of 2025. This IDV enables DLA to...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide a quantity of the pharmaceutical product PERJETA 420 MG/14 ML VIAL 14ML. The potential value of this delivery order is $51,059.52, with a completion date of February 12, 2024. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that holds numerous federal contracts and Indefinite Delivery Vehicles (IDVs) to supply pharmaceuticals...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $17,019.84 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 4563691587 PERJETA 420 MG/14 ML VIAL 14ML pharmaceutical products. This order is placed under DMS Pharmaceutical Group's existing indefinite delivery contract 4600082013 with DLA, which has a potential value of up to $4,999,999 and enables the agency to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $4,254.96 to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of Perjeta 420 mg/14 ml vials. This order is part of a larger indefinite delivery contract, SPE2DB, valued at up to $4,999,999 through 2025, which enables DLA to issue delivery orders for a broad range of pharmaceutical products to support the recurring medical supply needs of military health facilities...
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to supply the pharmaceutical product Perjeta 420 mg/14 ml vial. The order has a potential value of $8,277.00 and a completion date of January 12, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that provides a range of brand and generic prescription and over-the-counter drug supplies to the federal government, primarily the...
- This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,254.96 award is for the supply of PERJETA 420 MG/14 ML VIAL 14ML, a specialized oncology drug, to support the recurring medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA...
- The Defense Logistics Agency awarded a firm fixed price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the pharmaceutical product PERJETA 420 MG/14 ML VIAL 14ML. The $12,764.88 contract has a completion date of January 31, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that holds multiple federal contracts and indefinite delivery vehicles to supply a variety of pharmaceutical and medical products to the Department of...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The $25,529.76 contract is for the delivery of PERJETA 420 MG/14 ML VIAL 14ML pharmaceuticals with a completion date of February 5, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that provides a wide range of brand and generic prescription and over-the-counter drug supplies to the federal government, primarily the...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $25,529.76, is for the delivery of PERJETA (420 mg/14 ml) vials to support the recurring medical supply needs of Department of Defense (DoD) healthcare facilities. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at...
- The Defense Logistics Agency (DLA) awarded a $4,254.96 firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group that allows the DLA to issue delivery orders for a range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. The current...
- SPE2DB22D9316Indefinite Delivery Contract
- SPE2DB22D9316-SPE2DB24FYP60Delivery Order
The Defense Logistics Agency (DLA) awarded a $4,254.96 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide a PERJETA 420 MG/14 ML VIAL 14ML pharmaceutical product. This delivery order is issued under a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with DLA to supply a comprehensive range of pharmaceutical items to military health facilities worldwide. The contract has no set-aside designation. Through this IDC and other prime vendor agreements, DMS Pharmaceutical Group supports the recurring medical supply needs of the Department of Defense (DoD) and Department of Veterans Affairs (VA) by delivering a wide array of branded and generic prescription drugs, biologics, and medical consumables.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.3k | 6/28/24 |